EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review

Qin-Xiao Wang, Hai-Yang He, Ying-Luo Niu, Sheng Fang iD

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf053 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Qin-Xiao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Eosinophilia, Folliculitis, Janus Kinase Inhibitors, Piperidines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic pustular folliculitis (EPF) is an uncommon skin condition that presents as follicular papules or pustules. The treatment of EPF is challenging because of the high relapse rates. This study aims to evaluate the efficacy and safety of tofacitinib as a treatment for EPF. We present three patients with refractory EPF who were successfully treated with tofacitinib at our clinic. We also conducted a literature review using the PubMed database to gain further insight into this promising therapy. Our patients were effectively treated with tofacitinib. To the best of our knowledge, only three other patients with EPF treated with Janus kinase inhibitors have been reported and reviewed: one treated with tofacitinib and two with abrocitinib. Complete remission was observed in all patients – both our patients and the patients in the other studies – with no adverse events or relapses reported during an average follow-up period of 4.3 months. Tofacitinib may be an emerging alternative treatment option for patients with EPF. Larger randomized controlled studies are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophiliaFolliculitisJanus Kinase InhibitorsPiperidinesPyrimidinesPyrrolesSkin Diseases, VesiculobullousAdultFemaleHumansMaleMiddle AgedProtein Kinase InhibitorsTreatment Outcome

Substanzen

Janus Kinase InhibitorsPiperidinesProtein Kinase InhibitorsPyrimidinesPyrrolestofacitinib

Autor:innen und Institutionen

  • Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Sheng Fang

Zitieren

APA

Wang, Q. X., He, H. Y., Niu, Y. L., & Fang, S. (2025). Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf053

Vancouver

Wang QX, He HY, Niu YL, Fang S. Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf053

BibTeX
@article{Wang2025,
  author = {Wang, Qin-Xiao and He, Hai-Yang and Niu, Ying-Luo and Fang, Sheng},
  title = {Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf053}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche